NVDA
NVIDIA
-- 117.520 TSLA
Tesla
-- 235.860 INTC
Intel
-- 24.120 PLTR
Palantir
-- 86.100 AAPL
Apple
-- 215.240 
Update
$Repare Therapeutics (RPTX.US)$ Repare Therapeutics Doses First Patient in Phase 1 Clinical Trial of RP-3467, a Polθ ATPase Inhibitor
5 MINUTES AGO, 7:05 AM EDT
VIA BUSINESSWIRE
5 MINUTES AGO, 7:05 AM EDT
VIA BUSINESSWIRE
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment